The objective of this study was to compare the efficacy and safety of tirzepatide with titrated insulin degludec in individuals with type 2 diabetes who had inadequate glycemic control despite treatment with metformin alone or in combination with SGLT2 inhibitors.In this phase 3 study, participants aged 18 years or older, with a baseline glycated hemoglobin (HbA1c) of 7.0-10.5%, body mass index of at least 25 kg/m2, stable weight, and no prior insulin treatment, were enrolled across multiple centers in 13 countries
Morning and evening both work
Statements Author contributions SM, SP, MA, DeL, PK, SA, FN and JR conceived of the article, compiled the literature, and interpreted its contents
King SH, et al
our mission is to help people live longer, happier, and healthier lives